XML 40 R24.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Fair Value Measurements (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2018
Fair Value Disclosures [Abstract] |
Summary of Derivative Activity | The following table is a summary of the activity related to derivatives and hedges for the fiscal third quarters in 2018 and 2017:
| September 30, 2018 | October 1, 2017
(Dollars in Millions) | Sales | Cost of Products Sold | R&D Expense | Interest (Income) Expense | Other (Income) Expense | Sales | Cost of Products Sold | R&D Expense | Interest (Income) Expense | Other (Income) Expense
The effects of fair value, net investment and cash flow hedging: |  |  |  |  |  |  |  |  |  |
Gain (Loss) on fair value hedging relationship: |  |  |  |  |  |  |  |  |  |
Interest rate swaps contracts: |  |  |  |  |  |  |  |  |  |
Hedged items | $ | — |  | — |  | — |  | (7 | ) | — |  | — |  | — |  | — |  | (4 | ) | — |
Derivatives designated as hedging instruments | — |  | — |  | — |  | 7 |  | — |  | — |  | — |  | — |  | 4 |  | — |
Gain (Loss) on net investment hedging relationship: |  |  |  |  |  |  |  |  |  |
Cross currency interest rate swaps contracts: |  |  |  |  |  |  |  |  |  |
Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing | — |  | — |  | — |  | 25 |  | — |  | — |  | — |  | — |  | — |  | — |
Amount of gain or (loss) recognized in AOCI | — |  | — |  | — |  | 25 |  | — |  | — |  | — |  | — |  | — |  | — |
Gain (Loss) on cash flow hedging relationship: |  |  |  |  |  |  |  |  |  |
Forward foreign exchange contracts: |  |  |  |  |  |  |  |  |  |
Amount of gain or (loss) reclassified from AOCI into income (1) | 4 |  | 97 |  | 10 |  | — |  | (3 | ) | 5 |  | (63 | ) | (30 | ) | — |  | (49 | )
Amount of gain or (loss) recognized in AOCI (1) | 15 |  | 192 |  | (4 | ) | — |  | (1 | ) | 18 |  | (16 | ) | (39 | ) | — |  | (15 | )
Cross currency interest rate swaps contracts: |  |  |  |  |  |  |  |  |  |
Amount of gain or (loss) reclassified from AOCI into income | — |  | — |  | — |  | 34 |  | — |  | — |  |  | — |  | 106 |  | — |
Amount of gain or (loss) recognized in AOCI | $ | — |  | — |  | — |  | 35 |  | — |  | — |  | — |  | — |  | 114 |  | — |
The following table is a summary of the activity related to derivatives and hedges for the fiscal nine months in 2018 and 2017:
| September 30, 2018 | October 1, 2017
(Dollars in Millions) | Sales | Cost of Products Sold | R&D Expense | Interest (Income) Expense | Other (Income) Expense | Sales | Cost of Products Sold | R&D Expense | Interest (Income) Expense | Other (Income) Expense
The effects of fair value, net investment and cash flow hedging: |  |  |  |  |  |  |  |  |  |
Gain (Loss) on fair value hedging relationship: |  |  |  |  |  |  |  |  |  |
Interest rate swaps contracts: |  |  |  |  |  |  |  |  |  |
Hedged items | $ | — |  | — |  | — |  | 3 |  | — |  | — |  | — |  | — |  | (6 | ) | — |
Derivatives designated as hedging instruments | — |  | — |  | — |  | (3 | ) | — |  | — |  | — |  | — |  | 6 |  | — |
Gain (Loss) on net investment hedging relationship: |  |  |  |  |  |  |  |  |  |
Cross currency interest rate swaps contracts: |  |  |  |  |  |  |  |  |  |
Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing | — |  | — |  | — |  | 27 |  | — |  | — |  | — |  | — |  | — |  | — |
Amount of gain or (loss) recognized in AOCI | — |  | — |  | — |  | 27 |  | — |  | — |  | — |  | — |  | — |  | — |
Gain (Loss) on cash flow hedging relationship: |  |  |  |  |  |  |  |  |  |
Forward foreign exchange contracts: |  |  |  |  |  |  |  |  |  |
Amount of gain or (loss) reclassified from AOCI into income (1) | 50 |  | 175 |  | (242 | ) | — |  | (24 | ) | (34 | ) | (162 | ) | (131 | ) | — |  | (86 | )
Amount of gain or (loss) recognized in AOCI (1) | (3 | ) | 138 |  | (220 | ) | — |  | (16 | ) | 40 |  | 105 |  | (167 | ) | — |  | (59 | )
Cross currency interest rate swaps contracts: |  |  |  |  |  |  |  |  |  |
Amount of gain or (loss) reclassified from AOCI into income | — |  | — |  | — |  | 106 |  | — |  | — |  | — |  | — |  | 63 |  | — |
Amount of gain or (loss) recognized in AOCI | $ | — |  | — |  | — |  | 111 |  | — |  | — |  | — |  | — |  | 73 |  | — |
(1) Includes equity collar contracts. The equity collar contracts expired in December of 2017
Schedule of Derivatives Recorded in Consolidated Balance Sheet | As of September 30, 2018 and December 31, 2017, the following amounts were recorded on the Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges:
Line item in the Consolidated Balance Sheet in which the hedged item is included |  | Carrying Amount of the Hedged Liability |  | Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liability
(Dollars in Millions) |  | September 30, 2018 |  | December 31, 2017 |  | September 30, 2018 |  | December 31, 2017
Current Portion of Long-term Debt |  | $ | 601 |  |  | 597 |  |  | 1 |  |  | 2 |
Long-term Debt |  | 495 |  |  | 496 |  |  | (4 | ) |  | 3 |
Schedule of Effect of Derivatives not Designated as Hedging Instruments |
The following table is the effect of derivatives not designated as hedging instrument for the fiscal third quarters and fiscal nine months in 2018 and 2017:
|  |  |  | Gain/(Loss) Recognized In Income on Derivative | Gain/(Loss) Recognized In Income on Derivative
(Dollars in Millions) |  | Location of Gain /(Loss) Recognized in Income on Derivative |  | Fiscal Third Quarters Ended | Fiscal Nine Months Ended
Derivatives Not Designated as Hedging Instruments |  |  |  | September 30, 2018 |  | October 1, 2017 | September 30, 2018 |  | October 1, 2017
Foreign Exchange Contracts |  | Other (income) expense |  | $ | 49 |  |  | (12 | ) | (23 | ) |  | 22 |
Schedule of Effect of Net Investment Hedges |
The following table is the effect of net investment hedges for the fiscal third quarters in 2018 and 2017:
|  | Gain/(Loss) Recognized In Accumulated OCI |  | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income |  | Gain/(Loss) Reclassified From Accumulated OCI Into Income
(Dollars in Millions) |  | Fiscal Third Quarters Ended
|  | September 30, 2018 |  | October 1, 2017 |  |  |  | September 30, 2018 |  | October 1, 2017
Debt |  | $ | (50 | ) |  | (151 | ) |  | Other (income) expense |  | — |  |  | — |
Cross Currency interest rate swaps |  | $ | (75 | ) |  | — |  |  | Other (income) expense |  | — |  |  | — |
The following table is the effect of net investment hedges for the fiscal nine months in 2018 and 2017:
|  | Gain/(Loss) Recognized In Accumulated OCI |  | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income |  | Gain/(Loss) Reclassified From Accumulated OCI Into Income
(Dollars in Millions) |  | Fiscal Nine Months Ended
|  | September 30, 2018 |  | October 1, 2017 |  |  |  | September 30, 2018 |  | October 1, 2017
Debt |  | $ | 106 |  |  | (529 | ) |  | Other (income) expense |  | — |  |  | — |
Cross Currency interest rate swaps |  | $ | (37 | ) |  | — |  |  | Other (income) expense |  | — |  |  | — |
Summary of Activity Related to Equity Investments | The following table is a summary of the activity related to equity investments as of September 30, 2018:
(Dollars in Millions) |  | December 31, 2017 |  |  |  |  |  | September 30, 2018 |  |
|  | Carrying Value |  | Changes in Fair Value Reflected in Net Income (1) |  | Sales/ Purchases/Other (2) |  | Carrying Value |  | Non Current Other Assets
Equity Investments with readily determinable value |  | $ | 751 |  |  | (35 | ) |  | (19 | ) |  | 697 |  |  | 697 |
Equity Investments without readily determinable value |  | $ | 510 |  |  | 7 |  |  | 122 |  |  | 639 |  |  | 639 |
(1) Recorded in Other Income/Expense (2) Other includes impact of currency
Financial Assets and Liabilities at Fair Value | The Company’s significant financial assets and liabilities measured at fair value as of September 30, 2018 and December 31, 2017 were as follows:
|  | September 30, 2018 |  |  |  | December 31, 2017
(Dollars in Millions) |  | Level 1 |  | Level 2 |  | Level 3 |  | Total |  | Total(1)
Derivatives designated as hedging instruments: |  |  |  |  |  |  |  |  |  |
Assets: |  |  |  |  |  |  |  |  |  |
Forward foreign exchange contracts |  | $ | — |  |  | 551 |  |  | — |  |  | 551 |  |  | 418 |
Interest rate contracts (2)(4) |  | — |  |  | 19 |  |  | — |  |  | 19 |  |  | 7 |
Total |  | — |  |  | 570 |  |  | — |  |  | 570 |  |  | 425 |
Liabilities: |  |  |  |  |  |  |  |  |  |
Forward foreign exchange contracts |  | — |  |  | 401 |  |  | — |  |  | 401 |  |  | 402 |
Interest rate contracts (3)(4) |  | — |  |  | 269 |  |  | — |  |  | 269 |  |  | 165 |
Total |  | — |  |  | 670 |  |  | — |  |  | 670 |  |  | 567 |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  |  |
Assets: |  |  |  |  |  |  |  |  |  |
Forward foreign exchange contracts |  | — |  |  | 28 |  |  | — |  |  | 28 |  |  | 38 |
Liabilities: |  |  |  |  |  |  |  |  |  |
Forward foreign exchange contracts |  | — |  |  | 45 |  |  | — |  |  | 45 |  |  | 38 |
Other Investments: |  |  |  |  |  |  |  |  |  |
Equity investments (5) |  | 697 |  |  | — |  |  | — |  |  | 697 |  |  | 751 |
Debt securities(6) |  | $ | — |  |  | 11,155 |  |  | — |  |  | 11,155 |  |  | 5,310 |
Gross to Net Derivative Reconciliation |  | September 30, 2018 |  | December 31, 2017
(Dollars in Millions) |  |  |  |
Total Gross Assets |  | $ | 598 |  |  | 463 |
Credit Support Agreement (CSA) |  | (290 | ) |  | (76 | )
Total Net Asset |  | 308 |  |  | 387 |
Total Gross Liabilities |  | 715 |  |  | 605 |
Credit Support Agreement (CSA) |  | (443 | ) |  | (238 | )
Total Net Liabilities |  | $ | 272 |  |  | 367 |
(1) | 2017 assets and liabilities are all classified as Level 2 with the exception of equity investments of $751 million, which are classified as Level 1.
(2) | Includes $4 million and $7 million of non-current other assets for September 30, 2018 and December 31, 2017, respectively.
(3) | Includes $6 million and $9 million of non-current other liabilities for September 30, 2018 and December 31, 2017, respectively.
(4) | Includes cross currency interest rate swaps and interest rate swaps.
(5) | Classified as non-current other assets. The carrying amount of the equity investments were $697 million and $751 million as of September 30, 2018 and December 31, 2017, respectively.
(6) | Classified as cash equivalents and current marketable securities.
Marketable Securities | The Company's cash, cash equivalents and current marketable securities as of September 30, 2018 comprised:
| September 30, 2018
(Dollars in Millions) | Carrying Amount |  | Unrecognized Gain |  | Unrecognized Loss |  | Estimated Fair Value |  | Cash & Cash Equivalents |  | Current Marketable Securities
Cash | $ | 2,575 |  |  | — |  |  | — |  |  | 2,575 |  |  | 2,575 |  |  |
Other sovereign securities(1) | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |
U.S. reverse repurchase agreements | 2,260 |  |  | — |  |  | — |  |  | 2,260 |  |  | 2,260 |  |  |
Other reverse repurchase agreements | 479 |  |  | — |  |  | — |  |  | 479 |  |  | 479 |  |  |
Corporate debt securities(1) | 200 |  |  | — |  |  | — |  |  | 200 |  |  | 200 |  |  | — |
Money market funds | 1,763 |  |  | — |  |  | — |  |  | 1,763 |  |  | 1,763 |  |  |
Time deposits(1) | 932 |  |  | — |  |  | — |  |  | 932 |  |  | 932 |  |  |
Subtotal | 8,209 |  |  | — |  |  | — |  |  | 8,209 |  |  | 8,209 |  |  | — |
|  |  | Unrealized Gain |  | Unrealized Loss |  |  |  |  |  |
Government securities | 10,885 |  |  | — |  |  | (1 | ) |  | 10,884 |  |  | 7,835 |  |  | 3,049 |
Other sovereign securities | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Corporate debt securities | 271 |  |  | — |  |  | — |  |  | 271 |  |  | 12 |  |  | 259 |
Subtotal available for sale debt(2) | $ | 11,156 |  |  | — |  |  | (1 | ) |  | 11,155 |  |  | 7,847 |  |  | 3,308 |
Total cash, cash equivalents and current marketable securities |  |  |  |  |  |  |  |  |  |  |  |  | 16,056 |  |  | 3,308 |
(1) Held to maturity investments are reported at amortized cost and gains or losses are reported in earnings. (2) Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.
Schedule of Available for Sale Securities Maturities | The contractual maturities of the available for sale securities at September 30, 2018 are as follows:
(Dollars in Millions) |  | Cost Basis |  | Fair Value
Due within one year |  | $ | 11,079 |  |  | 11,078 |
Due after one year through five years |  | 77 |  |  | 77 |
Due after five years through ten years |  | — |  |  | — |
Total debt securities |  | $ | 11,156 |  |  | 11,155 |
Financial Liabilities not Measured at Fair Value | Financial Instruments not measured at Fair Value: The following financial liabilities are held at carrying amount on the consolidated balance sheet as of September 30, 2018:
(Dollars in Millions) |  | Carrying Amount |  | Estimated Fair Value
Financial Liabilities |  |  |  |
Current Debt |  | $ | 1,773 |  |  | 1,773 |
Non-Current Debt |  |  |  |
4.75% Notes due 2019 (1B Euro 1.1681) |  | 1,166 |  |  | 1,231 |
1.875% Notes due 2019 |  | 495 |  |  | 490 |
3% Zero Coupon Convertible Subordinated Debentures due in 2020 |  | 52 |  |  | 100 |
1.950% Notes due 2020 |  | 499 |  |  | 490 |
2.95% Debentures due 2020 |  | 548 |  |  | 551 |
3.55% Notes due 2021 |  | 448 |  |  | 454 |
2.45% Notes due 2021 |  | 349 |  |  | 345 |
1.65% Notes due 2021 |  | 998 |  |  | 967 |
0.250% Notes due 2022 (1B Euro 1.1681) |  | 1,165 |  |  | 1,172 |
2.25% Notes due 2022 |  | 996 |  |  | 973 |
6.73% Debentures due 2023 |  | 250 |  |  | 291 |
3.375% Notes due 2023 |  | 805 |  |  | 829 |
2.05% Notes due 2023 |  | 498 |  |  | 477 |
0.650% Notes due 2024 (750MM Euro 1.1681) |  | 872 |  |  | 881 |
5.50% Notes due 2024 (500 MM GBP 1.3123) |  | 651 |  |  | 793 |
2.625% Notes due 2025 |  | 748 |  |  | 719 |
2.45% Notes due 2026 |  | 1,991 |  |  | 1,884 |
2.95% Notes due 2027 |  | 996 |  |  | 956 |
2.90% Notes due 2028 |  | 1,493 |  |  | 1,420 |
1.150% Notes due 2028 (750MM Euro 1.1681) |  | 868 |  |  | 874 |
6.95% Notes due 2029 |  | 296 |  |  | 385 |
4.95% Debentures due 2033 |  | 498 |  |  | 559 |
4.375% Notes due 2033 |  | 856 |  |  | 912 |
1.650% Notes due 2035 (1.5B Euro 1.1681) |  | 1,735 |  |  | 1,774 |
3.55% Notes due 2036 |  | 988 |  |  | 945 |
5.95% Notes due 2037 |  | 991 |  |  | 1,252 |
3.625% Notes due 2037 |  | 1,486 |  |  | 1,433 |
3.40% Notes due 2038 |  | 990 |  |  | 926 |
5.85% Debentures due 2038 |  | 696 |  |  | 874 |
4.50% Debentures due 2040 |  | 538 |  |  | 573 |
4.85% Notes due 2041 |  | 297 |  |  | 330 |
4.50% Notes due 2043 |  | 495 |  |  | 532 |
3.70% Notes due 2046 |  | 1,971 |  |  | 1,884 |
3.75% Notes due 2047 |  | 991 |  |  | 951 |
3.50% Notes due 2048 |  | 742 |  |  | 689 |
Other |  | 22 |  |  | 22 |
Total Non-Current Debt |  | $ | 29,480 |  |  | 29,938 |

X
- Definition Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 320 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=75019621&loc=d3e62557-112803 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=82897076&loc=d3e27337-111563 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=82897076&loc=d3e27198-111563 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 320 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=82897076&loc=d3e27161-111563 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=82897076&loc=d3e27357-111563 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=82897076&loc=d3e27290-111563 + Details
Name: | us-gaap_AvailableForSaleSecuritiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13476-108611 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13467-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=75026489&loc=d3e13220-108610 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14172-108612 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 10 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13433-108611 + Details
Name: | us-gaap_FairValueByBalanceSheetGroupingTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash, cash equivalents, and investments. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5624171-113959 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5618551-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative liabilities at fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for other derivative instruments not designated as hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration